“Physiological concentrations of the soy-derived isoflavone genistein were shown to downregulate the androgen receptor of PCa cells via the estrogen receptor β, resulting in a modified response to hormonal stimuli. They also inhibit several steroid-metabolizing enzymes such as 5-α-reductase or aromatase. It has been postulated that these activities may be protective for PCa by creating a more favorable hormonal milieu.”
"After adjustment for confounders, an increased risk of advanced prostate cancer was found for the dietary intake of total isoflavones , genistein, daidzein and glycitein...This study revealed that dietary intake of isoflavones was associated with an elevated risk of advanced prostate cancer."
Clinical studies trump lab studies. Randomized clinical trials trump observational clinical studies. It's important not to take mouse studies very seriously.
Haven't taken genestein yet but I do take a variety of supplements, pausing them and rotating off to other supplements periodically. I'm on Lupron so it's difficult to know what is working. But latest scans looked good even compared with earlier scans done after I had been on Lupron more than a year. We'll see.
I don't think I'll be taking genistein. Since it has an affinity to ERb I thought it might activate it similar to estrogens. But I think it just passively takes up the spot and therefore blocks any potential estrogen-ERb action. So, bad for PCa (ERb activity is good).
Same thing for other soy isoflavones. Perhaps I could find a substance that binds to ERa and blocks it? (ERa activity is bad)
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.